Abstract:Drug companies have failed to keep their side of the bargain struck in the ambitious UK biosciences strategy, says its principal author, David Cooksey. Speaking at a seminar about medical research in the UK and the 2006 creation of the National Institute for Health Research (NIHR), he said that he was “hugely disappointed” by what had happened since the strategy was published in 2003 by the Biosciences Industry Growth Taskforce, which he chaired. The aim of the report was to make the UK a better place for innovation in the biosciences, and the report had strong industry involvement. “During the gestation of the report I had a huge come-on from the pharmaceutical companies for what I was trying to do,” Cooksey said. “But in fact they have largely removed themselves from basic research. To me, that is a huge disappointment because we were looking for parallel effort from the industry. “AstraZeneca now has only 7500 people working in the UK; Pfizer has closed the Sandwich laboratory; and Roche, who promised Gordon Brown [then chancellor of the exchequer] that they would put 30% of their research into the UK, didn’t.” He was also strongly critical of the industry’s pricing policies. Cooksey, a businessman and …

Cutting Science Budget Would Be “neanderthal” Behaviour, Expert Says

UK Scientists Would Lose Money and Influence under “brexit,” Says Lords Report

Final spending bills offer gloomy outlook for science

'Incomprehensible': scientists in France decry €900-million cut to research

Drug Industry Broke Promises on Medical Research, Say Experts

NIH Portfolio Allocation, Lemmings, and the Silent Spring: A Time-Capsule Commentary & Its Update

English Nhs Could Be 54bn Pound In Red By 2021 If Budget Or Output Doesn'T Increase

Research faces cuts as Dutch shift to the right

Speeding Up Access to New Drugs Threatens Evidence Based Medicine, Says Health Economist

NHS England’s Plans to Cut Specialised Service Providers from 270 to under 30 Might Not Be “sensible,” Conference Hears

Not Enough Cash Goes to Brain Tumour Research, Doctors Say

Any Foreseeable Growth in Nhs Will "feel Like A Cut" Because of Demographics and Cost Inflation, Report Says

Cuts to high-profile NIH efforts leave researchers reeling

Leading clinical academic warns of crisis in UK research

We can make the UK a science superpower — with a radical political manifesto

Devolution of Health Budget to Councils Could See NHS Spending Eroded, Expert Warns

Far-right governments seek to cut billions of euros from research in Europe

OHID: Cuts to disparities office could worsen health inequalities, doctors warn

Choosing Drugs on Price Alone Will Stifle Innovation, Says Report

Academics Should Leave Research Credentials Behind when They Move, Stern Report Says

Uk Must Not Relax Rules on Animal Studies to Harmonise with Europe, Scientists Say